sequencing of btk inhibitors in cll
Published 1 year ago • 197 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
2:13
resistance mechanisms in cll and the importance of genomic re-testing
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:09
real-world incidence of ibrutinib-related cardiotoxicity in cll: insights from the lls registry
-
1:57
the central role of bcr signaling in the pathogenesis of cll
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
2:34
sequencing of therapies in patients with r/r cll
-
1:46
genetic testing in cll and the role of biomarkers
-
2:16
immunoglobulin gene arrangements as clonal markers in cll
-
28:50
"leveraging single-cell transcriptomics to study complex diseases" - annique claringbould
-
22:23
the bcr signaling pathway in cll
-
38:07
trends in biopharma: glycosylation
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
4:48
exciting insights into the role of ror1 in cll
-
3:46
the characteristics and mode of action of ibrutinib for cll
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
1:39
the growing role of mrd as a clinical endpoint in cll
-
4:13
front-line and r/r updates in cll from eha
-
2:44
the structure and function of bcrs in the biology of cll
-
1:59
the expanding role of mrd in cll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
1:20
the importance of cardio-oncology in cll